Lv1
34 积分 2026-07-04 加入
Lentiviral particle-mediated generation of in-vivo CAR-T cells for treating refractory B-cell lymphoma
4天前
已完结
Promises and potential pitfalls of in vivo CAR gene therapy
9天前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
17天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy
1个月前
已完结
Targeted Delivery of mRNA with Polymer–Lipid Nanoparticles for In Vivo Base Editing
1个月前
已完结
Non-viral and mRNA-based strategies for next-generation CAR-T cell therapy
1个月前
已完结
皖公网安备34019202002308
